ONPATTRO™ (patisiran)
www.onpattro.com
www.onpattro.com
Onpattro (patisiran) in indicated for the treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adults.
Onpattro (patisiran) in indicated for the treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adults.